Skip to content
‹ Back to IndustriesHealthcare

What Should Building Managers Do If COVID Doesn’t Go Away?

We all want the coronavirus to go away and for COVID-19, social distancing and everything that goes with it to be remembered as a horrible part of a weird year. There are some encouraging signs, with Pfizer announcing promising news about a vaccine candidate and other medical companies making progress. But what if the…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share
What Should Building Managers Do If COVID Doesn’t Go Away?

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

We all want the coronavirus to go away and for COVID-19, social distancing and everything that goes with it to be remembered as a horrible part of a weird year.

There are some encouraging signs, with Pfizer announcing promising news about a vaccine candidate and other medical companies making progress. But what if the vaccine isn’t effective, the virus mutates or it returns in different forms, like the flu?

Those possibilities are why everyone, but especially building managers, must ask the question of what we do if COVID doesn’t go away, said John Shanahan, President of Ionogen.

“Maybe it’s a mutation or maybe the flu gets smarter. We have to have more long-term strategies for getting people back into business,” Shanahan said.

Shanahan has found his company’s hypochlorous solutions highly effective in Ionogen’s own office, with none of his team of 50 testing positive for COVID during the pandemic.

“In February, when this really started to ramp up, we deployed all the humidification devices in our building. Because we made surface sanitizers and disinfectants and they were still trying to figure out what COVID was, we put the air sanitizers up as a preventative measure,” he said. “We were so busy February, March, April and May that there was no stopping. But because we have both the physical staff in our manufacturing division and we needed to be able to collaborate, we just added more units into our space.”

Now, they’re looking into the positive results of hypochlorous actually getting into the upper respiratory areas and potentially killing the virus.

“We’re very excited about the future of where this is going to take us. We will continue, as always, to do more testing and trials and the continued research on this,” Shanahan said. “We’re committed to science, and we like proof. Anecdotes are great, and we’ve got a lot of anecdotes about how this has worked up until now. Now, we’ll continue to dig down into the science. Hypochlorous could very well be the antidote without having to take the immunization.”

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Why young children die from local anesthetic overdoses in dental offices

Why young children die from local anesthetic overdoses in dental offices

Dentist anesthesiologists Stanley Malamed and Jason Brady told HealthFirst's Health First Talks podcast that fatal local anesthetic overdoses in young dental patients follow a chain of small errors: one-visit treatment plans, plain 3% mepivacaine, four quadrants injected at once and adult cartridges. Oral Health Group estimates LAST at 0.27 cases per 1,000 administrations. Brady caps his anesthetic tray at 90% of the maximum recommended dose.

  • 01Plain 3% mepivacaine is a sound one-quadrant drug for a child; beyond one quadrant, Malamed says epinephrine must be in the cartridge because it holds the drug in the nerve and keeps blood levels down.
  • 02Oral Health Group estimates LAST at about 0.27 cases per 1,000 local anesthetic administrations and reports cardiac signs come before any nervous system warning in about 20% of atypical cases.
  • 03Brady preps a tray holding 90% of the patient's calculated maximum recommended dose so a distracted operator cannot reach past it mid-case.

Oct 16, 2026

Suki raises $90M to take its AI scribe beyond note-taking

Suki raises $90M to take its AI scribe beyond note-taking

The funding backs a bet that scribes become clinicians' main AI interface, which changes how health systems evaluate them.

  • 01An ambient scribe already holds the patient context from the visit, and in early testing that context drove clinicians to prefer context-aware UpToDate answers 83% of the time.
  • 02Once a scribe starts answering clinical questions, note accuracy stops being enough to judge it. Regenstrief and Suki are building a framework that could add standardized metrics for answers too.

Oct 15, 2026

Harbor Health to buy 27 Village Medical clinics in Greater Houston

Harbor Health to buy 27 Village Medical clinics in Greater Houston

Harbor Health's purchase of Village Medical clinics in Houston is expected to close at the end of 2026. The 27 clinics are the primary care home for Harbor members in four counties.

  • 01Harbor's $0 specialist benefit only applies when a Harbor clinician makes the referral. For Houston employers, the test is whether employees will use the 27 clinics as their first stop.

Oct 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512